Drug General Information
Drug ID
D08ROQ
Former ID
DNC001258
Drug Name
S-25585
Drug Type
Small molecular drug
Indication Eating disorders reduction in food intake [ICD9: 307.5; ICD10:F50] Investigative [536225]
Company
Servier
Structure
Download
2D MOL

3D MOL

Formula
C22H29F3N4O6S
Canonical SMILES
C1CC(CCC1CNS(=O)(=O)C2CCC(CC2[N+](=O)[O-])C(F)(F)F)C(=O<br />)NNC(=O)C3=CC=CC=C3
InChI
1S/C22H29F3N4O6S/c23-22(24,25)17-10-11-19(18(12-17)29(32)33)36(34,35)26-13-14-6-8-16(9-7-14)21(31)28-27-20(30)15-4-2-1-3-5-15/h1-5,14,16-19,26H,6-13H2,(H,27,30)(H,28,31)
InChIKey
MODMVZPKMVZXFO-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Neuropeptide Y receptor 5 Target Info Antagonist [536225]
Neuropeptide Y receptor type 1 Target Info Antagonist [536225]
KEGG Pathway Neuroactive ligand-receptor interactionhsa04024:cAMP signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway FSH Signaling Pathway
Reactome Peptide ligand-binding receptors
G alpha (i) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
Endothelin Pathways
GPCR downstream signaling
References
Ref 536225Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36.
Ref 536225Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.